SCHEMBL6609844

SCHEMBL6609844

C#Cc1ccc(NC(=O)O)c([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HCAR3 P49019 3/20 0.46
APP P05067 1/20 0.44
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
GLA P06280 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 2/20 0.42
KCNMA1 Q12791 2/20 0.42
MEN1 O00255 1/20 0.41
ABCB1 P08183 1/20 0.41
ABCC1 P33527 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22636823 0.85 MAPT (0.55) ALDH1A1HCAR3APPMAPTNPSR1
SCHEMBL5562552 0.80 KMT2A (0.43) ALDH1A1MAPTNPSR1NPC1RAB9A
SCHEMBL483782 0.80 HCAR3 (0.54) ALDH1A1HCAR3MAPTNPC1RAB9A
SCHEMBL2465627 0.79 ALDH1A1 (0.45) ALDH1A1HCAR3MAPTNPSR1NPC1
SCHEMBL2465632 0.79 ALDH1A1 (0.45) ALDH1A1HCAR3MAPTNPSR1NPC1
SCHEMBL18493542 0.79 HPGD (0.39) NPC1RAB9AKMT2AMEN1
SCHEMBL1704376 0.78 ALDH1A1 (0.71) ALDH1A1MAPTNPC1RAB9AMAPK1
SCHEMBL7462935 0.77 ABCB1 (0.52) ALDH1A1HCAR3MAPTRAB9AKMT2A
SCHEMBL16235764 0.76 APP (0.69) ALDH1A1APPMAPTNPSR1NPC1
SCHEMBL6611147 0.76 HCAR3 (0.52) ALDH1A1HCAR3APPMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed
EP-1379511-A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 EP disclosed
WO-2002083652-A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2002-10-24 WO disclosed
EP-1224175-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029012-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed